Foundations of Type 1 Diabetes:
The Non-Negotiables
The few things that truly matter, and why. Read the plain version with Jude, earn your way into the evidence with Grace, then the full picture with John. Start here; everything else builds on it.
How we teach: three rules, borrowed from Taleb
You earn each level by showing you understand it, not by scrolling past it. We only teach what we would use on ourselves and the people we love.
Understanding beats memory and luck, so the checks reshuffle every time you retry. A pass means you got it, not that you guessed it. And we teach you to tell a trend (signal) from one reading (noise).
We give you the scaffolding and get out of your way. Roam where your curiosity leads, go as deep as you want, and ask Grace anything. We will not teach a bird how to fly.
Newly diagnosed, a parent, or supporting someone? Ask Grace anything, then take it to your care team.
One page, three depths
This guide compounds: each layer rests on the one beneath it. Read Jude’s plain version, then pass a short understanding check to open Grace, then another to open John. You can roam freely within a layer; you cannot skip ahead a layer, because the next one would not make sense and you would be standing on a gap.
The whole thing, in plain words
Type 1 diabetes is one thing at heart: the body has lost the cells that make insulin, so insulin now has to come from outside, every day, for life. This is not caused by sugar, weight, or anything you did. It is the immune system removing those cells by mistake. The job from now on is to put insulin in at roughly the right amount and the right time, then learn from what happens next.1
Insulin is not optional, and it is not a cure that can be paused. It is the missing signal that lets glucose move out of the blood and into cells for energy. Without it, glucose climbs and the body starts burning fat, which makes ketones; high glucose with rising ketones is diabetic ketoacidosis (DKA), an emergency. This is why background insulin is never skipped, even on a day with no food.2
A few things matter more than everything else, and they are the whole of this hub:
- Insulin, every day. Background insulin keeps the system safe between meals and overnight; mealtime insulin covers the food. Both, always.
- Watch the trend, not just the dot. A continuous glucose monitor (CGM) shows where glucose is and where it is heading, so you act early and gently.
- Treat a low promptly. Below 4.0 mmol/L (70 mg/dL) is a hypo; fast sugar fixes it. A low is the one thing that needs attention now, not later.3
- Food is information, not a moral test. Carbohydrate moves glucose most, so knowing roughly how much is in a meal is what lets the insulin match it.
One more thing that surprises people. For the first months after diagnosis, the body often still makes a little insulin; this is the honeymoon, and doses are usually lower. As it fades over one to three years, doses rise. That is normal physiology, not a step backwards.
Does this match the life of the person living it? On a hard day, you do not need to master everything. You need to keep insulin going, treat a low fast, and not turn a high number into a verdict on yourself. The basics, done kindly, carry you.The Pemberton lens, lived recognisability, one of the four GNL appraisal lenses.
What is happening underneath, and what the evidence says
Type 1 is autoimmune, and mostly silent until late
In type 1 diabetes the immune system removes the insulin-producing beta cells in the pancreas over months to years. By the time the familiar symptoms appear (thirst, frequent urination, weight loss), most of the working beta cells are already gone (Atkinson 2014).1 This is why type 1 is not preventable by diet or weight, and why insulin replacement is not a lifestyle choice but a physiological necessity.
Background and mealtime insulin do two different jobs
The body needs insulin even when no food is eaten, because the liver releases glucose continuously. Background (basal) insulin covers that; mealtime (bolus) insulin covers the carbohydrate in food. A working pancreas adjusts both every few seconds; type 1 asks the person and their tools to do it from outside the loop. Missing background insulin is the dominant route into DKA, which on a pump can develop within two to three hours of a failed infusion site because there is no long-acting reservoir to fall back on.2
Of the three macronutrients, carbohydrate raises glucose the most and the fastest. Counting it to within roughly 10 to 20 g is good enough for most meals; the aim is a sensible match, not a perfect one.4
Why the hypo line is set at 4.0, not 3.3
Physiologically, hypoglycaemia begins below about 3.3 mmol/L (60 mg/dL), yet the standard treatment threshold is set higher at 4.0 mmol/L (70 mg/dL). The reason is sensor accuracy: a CGM reading in the low range counts as accurate if it is within about 0.8 mmol/L (15 mg/dL) of true glucose, so a true 3.2 can read as 4.0. Treating at 4.0 catches almost all true lows before they become dangerous (ATTD/IHSG 2019; ADA 2024; ISPAD 2024).3
The in-range zone, 3.9 to 10.0 mmol/L (70 to 180 mg/dL), is the population-standard target band, not a personal target. Your own band is set with your care team.
A clean threshold like 4.0 is a deliberate, evidence-based safety margin, not a hard biological wall. When a number is handed to you as a rule, ask what it is protecting against and how it was chosen; a margin built for sensor error is doing useful work even when it looks arbitrary.The Goldacre lens, evidence-grade discipline, one of the four GNL appraisal lenses.
Foundations as a system: what to build first
Why this order, and not another
Foundations is sequenced on purpose. Each layer is the floor the next one stands on, so building out of order leaves a gap you only discover under pressure. The whole of type 1 management reduces, at the base, to one loop the body used to run for free: sense glucose, decide insulin, act, learn. Everything in the deeper guides is a refinement of that loop, not a replacement for it.
| Build this | Because it carries | The risk if skipped |
|---|---|---|
| Insulin, basal and bolus | Everything; nothing else works without it | DKA from missed background insulin |
| CGM and the trend | The feedback that makes every other decision possible | Acting on stale, single readings |
| Treating lows | The acute safety floor | Severe hypoglycaemia needing third-party help |
| Carbohydrate awareness | Matching mealtime insulin to food | Avoidable post-meal swings |
| Measuring what matters | Knowing whether the system is working over time | Chasing the wrong number, or every number |
D This ordering is a GNL teaching model, not a clinical protocol. It is built on settled mechanism (Atkinson 2014; DKA physiology) plus the foundations sequence; the priority ranking itself is editorial.1 5
The safety floor comes before optimisation
There is an asymmetry worth naming. A high glucose for a few hours is uncomfortable and, repeated over years, raises long-term risk; a severe low can be dangerous within minutes. So the foundations are weighted toward the catastrophic-but-rare event, not the uncomfortable-but-common one. Background insulin and prompt hypo treatment are non-negotiable precisely because their failure modes are the steep ones. Optimisation, tighter ranges, finer carb counting, comes after the floor is solid, never instead of it.
Background insulin is not skipped for a no-food day, a sick day, or a “good” glucose on an adjunct medication. Omitted basal is the silent route to DKA; on a pump, a failed site can reach ketosis within two to three hours.2
Where the foundations lead
Once the floor is solid, the rest of GNL opens up: CGM in depth, mealtime insulin and timing, HbA1c and time in range as the over-time measures, exercise, and automated insulin delivery and how it changes the loop. None of those replace foundations; they sharpen it. The honest framing is that mastery here is not knowing more facts, it is running the basic loop reliably enough that the advanced tools have something solid to refine.
Build for the worst plausible day, not the average one. The rare severe low is the event that does lasting harm, so the foundations are weighted to make that event rare and survivable. Robustness first; optimisation is a luxury you earn once the floor holds.The Taleb lens, robustness to outliers, one of the four GNL appraisal lenses.
This priority order is a model, and a model should be honest about its grade. The mechanism beneath it is settled; the ranking on top is editorial judgement, not trial-derived. Treat it as a sound default to start from, then let your own data and your care team refine it. The map is not the territory.The Hayes lens, technical and methodological rigour, one of the four GNL appraisal lenses.
The non-negotiables, summarised
Glucose never lies; it just tells you what the system is doing. Get the few non-negotiables steady first, then build from there.
This page is the taster. The full Foundations journey, three modules and their 30 questions, with your progress saved, lives in Learn with Grace. Glucose never lies; come and learn to read it.
References
Evidence grades A (strongest) to D (editorial or working analysis).
- Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. The Lancet. 2014;383(9911):69-82. (Autoimmune beta-cell loss; most working beta cells gone by symptom onset.) A
- Insulin essentiality and DKA mechanism: settled clinical physiology, synthesised in the GNL Grace evidence base (insulin-safety and infusion-set concepts; ISPAD 2024 Ch13 sick-day rules). Omitted basal and infusion-site failure as the dominant DKA routes. A
- Hypoglycaemia treatment threshold 4.0 mmol/L (70 mg/dL) and CGM accuracy margin: ATTD / IHSG consensus 2019; ADA Standards of Care 2024, Section 6; ISPAD 2024 Ch12, Hypoglycaemia. A
- Carbohydrate-counting accuracy thresholds (within ~10 to 20 g): Smart CE, et al. 2009 (paediatric); Brazeau AS, et al. 2013 (adult). A
- GNL Foundations Framework: the recommended foundations sequence and ordering. GNL Grace working analysis, evidence grade D (mechanism A, ordering editorial). D
One page, three voices: Jude, Grace, John. Population-average, not personalised.